Munoz de Chavez M, Chavez A, Valles V, et al. The nopal: a plant of manifold qualities.
World Rev Nutr Diet.
1995;77:109-134.
Frati Munari AC, Vera Lastra O, Ariza Andraca CR. Evaluation of nopal capsules in diabetes mellitus [in Spanish; English abstract].
Gac Med Mex.
1992;128:431-436.
Cardenas Medellin ML, Serna Saldivar SO, Velazco de la Garza J. Effect of raw and cooked nopal
(Opuntia ficus indica)
ingestion on growth and profile of total cholesterol, lipoproteins, and blood glucose in rat [in Spanish; English abstract].
Arch Latinoam Nutr.
1998;48:316-323.
Frati AC, Gordillo BE, Altamirano P, et al. Influence of nopal intake upon fasting glycemia in type II diabetics and healthy subjects.
Arch Invest Med (Mex).
1991;22:51-56.
Frati-Munari AC, Del Valle-Martinez LM, Ariza-Andraca CR, et al. Hypoglycemic action of different doses of nopal (
Opuntia streptacantha
Lemaire) in patients with type II diabetes mellitus [ in Spanish; English abstract].
Arch Invest Med (Mex).
1989;20:197-201.
Frati-Munari AC, Gordillo BE, Altamirano P, et al. Hypoglycemic effect of
Opuntia streptacantha
Lemaire in NIDDM.
Diabetes Care.
1988;11:63-66.
Frati-Munari AC, Fernandez-Harp JA, de la Riva H, et al. Effects of nopal (
Opuntia
sp.) on serum lipids, glycemia and body weight.
Arch Invest Med (Mex).
1983;14:117-125.
Frati-Munari AC, de Leon C, Ariza-Andraca R, et al. Effect of a dehydrated extract of nopal (
Opuntia ficus indica
Mill.) on blood glucose [ in Spanish; English abstract].
Arch Invest Med (Mex).
1989;20:211-216.
Frati Munari AC, Quiroz Lazaro JL, Altamirano Bustamante P, et al. The effect of various doses of nopal (
Opuntia streptacantha
Lemaire) on the glucose tolerance test in healthy individuals [in Spanish; English abstract].
Arch Invest Med (Mex).
1988;19:143-148.
Munoz de Chavez M, Chavez A, Valles V, et al. The nopal: a plant of manifold qualities.
World Rev Nutr Diet.
1995;77:109-134.
Frati Munari AC, Vera Lastra O, Ariza Andraca CR. Evaluation of nopal capsules in diabetes mellitus [in Spanish; English abstract].
Gac Med Mex.
1992;128:431-436.
Cardenas Medellin ML, Serna Saldivar SO, Velazco de la Garza J. Effect of raw and cooked nopal
(Opuntia ficus indica)
ingestion on growth and profile of total cholesterol, lipoproteins, and blood glucose in rat [in Spanish; English abstract].
Arch Latinoam Nutr.
1998;48:316-323.
Frati AC, Gordillo BE, Altamirano P, et al. Influence of nopal intake upon fasting glycemia in type II diabetics and healthy subjects.
Arch Invest Med (Mex).
1991;22:51-56.
Frati-Munari AC, Fernandez-Harp JA, de la Riva H, et al. Effects of nopal (
Opuntia
sp.) on serum lipids, glycemia and body weight.
Arch Invest Med (Mex).
1983;14:117-125.
Park EH, Kahng JH, Paek EA. Studies on the pharmacological action of cactus: identification of its anti-inflammatory effect.
Arch Pharm Res.
1998;21:30-34.
Jonas A, Rosenblat G, Krapf D, et al. Cactus flower extracts may prove beneficial in benign prostatic hyperplasia due to inhibition of 5alpha reductase activity, aromatase activity and lipid peroxidation.
Urol Res.
1998;26:265-270.
Frati-Munari AC, Gordillo BE, Altamirano P, et al. Hypoglycemic effect of
Opuntia streptacantha
Lemaire in NIDDM.
Diabetes Care.
1988;11:63-66.
Frati Munari AC, Quiroz Lazaro JL, Altamirano Bustamante P, et al. The effect of various doses of nopal (
Opuntia streptacantha
Lemaire) on the glucose tolerance test in healthy individuals [in Spanish; English abstract].
Arch Invest Med (Mex).
1988;19:143-148.
Frati Munari AC, Vera Lastra O, Ariza Andraca CR. Evaluation of nopal capsules in diabetes mellitus [in Spanish; English abstract].
Gac Med Mex.
1992;128:431-436.
Frati-Munari AC, de Leon C, Ariza-Andraca R, et al. Effect of a dehydrated extract of nopal (
Opuntia ficus indica
Mill.) on blood glucose [ in Spanish; English abstract].
Arch Invest Med (Mex).
1989;20:211-216.
Wiese J, McPherson S, Odden MC, Shlipak MG. Effect of
Opuntia ficus indica
on symptoms of the alcohol hangover.
Arch Intern Med.
2004;164:1334-1340.
Linares E, Thimonier C, Degre M. The effect of NeOpuntia on blood lipid parameters—risk factors for the metabolic syndrome (syndrome X).
Adv Ther.
2007;24:1115-1125.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.